Triple-negative breast cancer: understanding Wnt signaling in drug resistance

por Merikhian, Parnaz, Eisavand, Mohammad Reza, Farahmand, Leila
Publicado 2021

Crosstalk between MUC1 and VEGF in angiogenesis and metastasis: a review highlighting roles of the MUC1 with an emphasis on metastatic and angiogenic signaling

por Khodabakhsh, Farnaz, Merikhian, Parnaz, Eisavand, Mohammad Reza, Farahmand, Leila
Publicado 2021

MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy

por Hosseinzadeh, Aysooda, Merikhian, Parnaz, Naseri, Nazanin, Eisavand, Mohammad Reza, Farahmand, Leila
Publicado 2022

Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk

por Barzaman, Khadijeh, Vafaei, Rana, Samadi, Mitra, Kazemi, Mohammad Hossein, Hosseinzadeh, Aysooda, Merikhian, Parnaz, Moradi-Kalbolandi, Shima, Eisavand, Mohammad Reza, Dinvari, Houra, Farahmand, Leila
Publicado 2022

Recombinant nanobody against MUC1 tandem repeats inhibits growth, invasion, metastasis, and vascularization of spontaneous mouse mammary tumors

por Merikhian, Parnaz, Darvishi, Behrad, Jalili, Neda, Esmailinejad, Mohammad Reza, Khatibi, Azadeh Sharif, Kalbolandi, Shima Moradi, Salehi, Malihe, Mosayebzadeh, Marjan, Barough, Mahdieh Shokrollahi, Majidzadeh‐A, Keivan, Yadegari, Fatemeh, Rahbarizadeh, Fatemeh, Farahmand, Leila
Publicado 2021